Globocare Pharmaceuticals Private Limited
About Globocare Pharmaceuticals Private Limited
Data last updated:
Globocare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 30 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC236710. Its GSTIN is 10AAECG7450P1ZG (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nibha Rani and Reena Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 68 2nd Floor Avtar Enclave, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2023, the company reported a revenue of ₹44.26 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹2.72 Lakh (net margin -6.1%) and EBITDA of -₹1.09 Lakh (EBITDA margin -2.5%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹6.15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Globocare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address68 2nd Floor Avtar Enclave, New Delhi, Delhi, India – 110063
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Globocare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Globocare Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Globocare Pharmaceuticals Private Limited, buy the company report.
Financials of Globocare Pharmaceuticals Private Limited
FY 2023 filings availableGlobocare Pharmaceuticals Private Limited reported revenue of ₹44.26 Lakh (down 20% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 20% fall in the latest year. EBITDA fell 148% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.5% | ||||
| Net Profit Margin | -6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Globocare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Globocare Pharmaceuticals Private Limited
Globocare Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nibha Rani | Director | 30 May 2012 | 14 Years 5 Months | Current |
| Reena Singh | Director | 30 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Globocare Pharmaceuticals Private Limited is audited by SHIVRAJSOHAN& COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIVRAJSOHAN& COMPANY | FY 2017 | 021365N |
Shareholding
The shareholding of Globocare Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Globocare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Jan 2019 | 100241076 | Vijaya Bank | ₹6.15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Globocare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Globocare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Globocare Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECG7450P1ZG | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Globocare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Globocare Pharmaceuticals Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Ritendra Kumar ceased to be Director on 08 Mar 2019.
Frequently asked questions
Globocare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 30 May 2012 (14+ years old) and is registered under CIN U24232DL2012PTC236710.
Globocare Pharmaceuticals has 2 current directors:
- Nibha Rani - Director
- Reena Singh - Director
The latest financial statements of Globocare Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Globocare Pharmaceuticals is 10AAECG7450P1ZG, registered in Bihar.
The CIN (Corporate Identification Number) of Globocare Pharmaceuticals is U24232DL2012PTC236710. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Globocare Pharmaceuticals was incorporated on 30 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Ritendra Kumar ceased to be Director on 08 Mar 2019. Reena Singh was appointed as Director on 30 Jan 2019. Nibha Rani was appointed as Director on 30 May 2012.
The registered office of Globocare Pharmaceuticals is at 68 2nd Floor Avtar Enclave, New Delhi, Delhi, India – 110063.
Globocare Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Globocare Pharmaceuticals has open charges of ₹6.15 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
